T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEPPZ
1026
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $31.7M | ﹤0.01% |
585,438
-79,447
| -12% | -$4.42M |
|
|
TWKS
1027
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $31.4M | ﹤0.01% |
2,224,996
+22,252
| +1% | +$385K |
|
1028
TechTarget
TTGT
$278M
| $31.3M | ﹤0.01% |
476,782
+20,963
| +5% | +$1.46M |
|
1029
Utah Medical Products
UTMD
$226M
| $31.3M | ﹤0.01% |
364,512
-700
| -0.2% | -$59.7K |
|
1030
United Therapeutics
UTHR
$21.4B
| $31.3M | ﹤0.01% |
132,774
+73,913
| +126% | +$15M |
|
1031
Edison International
EIX
$27.5B
| $31.2M | ﹤0.01% |
493,626
-52,086
| -10% | -$3.53M |
|
1032
Legend Biotech
LEGN
$3.95B
| $31.2M | ﹤0.01% |
+567,155
| New | +$24M |
|
1033
CBRE Group
CBRE
$44.3B
| $31.2M | ﹤0.01% |
423,736
-53,924
| -11% | -$4.34M |
|
1034
T. Rowe Price
TROW
$23.6B
| $31.2M | ﹤0.01% |
274,496
-35,315
| -11% | -$4.49M |
|
1035
International Seaways
INSW
$4.81B
| $31.1M | ﹤0.01% |
1,467,700
-647,094
| -31% | -$14.2M |
|
1036
Ares Management
ARES
$32.5B
| $30.9M | ﹤0.01% |
544,164
+484,275
| +809% | +$33.5M |
|
1037
Cogent Communications
CCOI
$579M
| $30.9M | ﹤0.01% |
508,278
+5,166
| +1% | +$318K |
|
1038
Cedar Fair
FUN
$1.68B
| $30.9M | ﹤0.01% |
702,576
-1,642,246
| -70% | -$79.6M |
|
1039
Braze
BRZE
$3.26B
| $30.7M | ﹤0.01% |
847,360
+298,790
| +54% | +$10.9M |
|
1040
Amplitude
AMPL
$1.63B
| $30.6M | ﹤0.01% |
2,141,579
+223,041
| +12% | +$3.91M |
|
|
LTHM
1041
DELISTED
Livent Corporation
LTHM
| $30.3M | ﹤0.01% |
1,334,286
+166,582
| +14% | +$4.29M |
|
|
AZPN
1042
DELISTED
Aspen Technology Inc
AZPN
| $30.2M | ﹤0.01% |
+164,230
| New | +$29.2M |
|
|
PCSB
1043
DELISTED
PCSB Financial Corporation
PCSB
| $30.1M | ﹤0.01% |
1,578,896
| – | – |
|
1044
eBay
EBAY
$45.9B
| $30.1M | ﹤0.01% |
721,230
-167,497
| -19% | -$8.16M |
|
1045
Advantage Solutions
ADV
$420M
| $30M | ﹤0.01% |
315,671
-32,507
| -9% | -$3.93M |
|
|
BERY
1046
DELISTED
Berry Global Group, Inc.
BERY
| $29.9M | ﹤0.01% |
596,334
-3,178
| -0.5% | -$165K |
|
1047
American Public Education
APEI
$828M
| $29.8M | ﹤0.01% |
1,843,974
-1,065
| -0.1% | -$18.1K |
|
1048
Entrada Therapeutics
TRDA
$290M
| $29.7M | ﹤0.01% |
2,437,498
-57,216
| -2% | -$434K |
|
1049
dLocal
DLO
$4.17B
| $29.5M | ﹤0.01% |
1,124,432
-338,139
| -23% | -$8.66M |
|
1050
Nasdaq
NDAQ
$54.2B
| $29.4M | ﹤0.01% |
578,997
-72,870
| -11% | -$3.86M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.